Klaria Pharma Holding Stock Fundamentals
| KLAR Stock | SEK 0.38 0.02 5.56% |
Klaria Pharma Holding fundamentals help investors to digest information that contributes to Klaria Pharma's financial success or failures. It also enables traders to predict the movement of Klaria Stock. The fundamental analysis module provides a way to measure Klaria Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klaria Pharma stock.
Klaria |
Klaria Pharma Holding Company Return On Asset Analysis
Klaria Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Klaria Pharma Return On Asset | -0.29 |
Most of Klaria Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Klaria Pharma Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Klaria Pharma Holding has a Return On Asset of -0.2915. This is 96.67% lower than that of the Healthcare sector and 120.67% lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on asset for all Sweden stocks is 108.21% higher than that of the company.
Klaria Pharma Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Klaria Pharma's current stock value. Our valuation model uses many indicators to compare Klaria Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Klaria Pharma competition to find correlations between indicators driving Klaria Pharma's intrinsic value. More Info.Klaria Pharma Holding is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Klaria Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Klaria Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Klaria Pharma's earnings, one of the primary drivers of an investment's value.Klaria Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klaria Pharma's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klaria Pharma could also be used in its relative valuation, which is a method of valuing Klaria Pharma by comparing valuation metrics of similar companies.Klaria Pharma is currently under evaluation in return on asset category among related companies.
Klaria Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (9.48) % | |||
| Current Valuation | 88.14 M | |||
| Shares Outstanding | 63.1 M | |||
| Shares Owned By Insiders | 10.73 % | |||
| Shares Owned By Institutions | 9.75 % | |||
| Price To Earning | (18.43) X | |||
| Price To Book | 1.42 X | |||
| Price To Sales | 8.00 X | |||
| Gross Profit | 5.87 M | |||
| EBITDA | (39.41 M) | |||
| Net Income | (53.53 M) | |||
| Cash And Equivalents | 25.49 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 1.02 M | |||
| Current Ratio | 0.68 X | |||
| Book Value Per Share | 0.97 X | |||
| Cash Flow From Operations | (24.8 M) | |||
| Earnings Per Share | (1.72) X | |||
| Beta | 0.39 | |||
| Market Capitalization | 39.49 M | |||
| Total Asset | 118.31 M | |||
| Retained Earnings | (9 M) | |||
| Working Capital | 41 M | |||
| Current Asset | 44 M | |||
| Current Liabilities | 3 M | |||
| Z Score | 22.8 | |||
| Net Asset | 118.31 M |
About Klaria Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Klaria Pharma Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klaria Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klaria Pharma Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Klaria Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Klaria Pharma's short interest history, or implied volatility extrapolated from Klaria Pharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Klaria Pharma Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Klaria Stock analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |